BioWorld MedTech

June 14, 2010

Sicel touts dose device at radiotherapeutics meeting

Undergoing radiation therapy is often the best chance a patient has at getting rid of a tumor, but the treatment sometimes comes with an unfortunate – even fatal – price if the patient receives too much. (Medical Device Daily) Read More

AAPM; clinics responsible for QA, but industry must pitch in

Financings roundup: SonoSite to repurchase up to $50M of its common stock

Checkpoint's neurostimulation device launched nationwide

International report: SFDA clears China Medical Technologies' HPV-DNA chip

MDD's food for med-tech thought

Deals roundup: Orthopaedic Synergy wraps up Praxim acquisition

Agreements/contracts: TransEnterix selects Syspro ERP software for real-time data

Court Report: U.S. wins $2.75 million in Medicaid fraud settlement

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...